Stay updated on Gantenerumab Long-term Safety in AD Clinical Trial
Sign up to get notified when there's something new on the Gantenerumab Long-term Safety in AD Clinical Trial page.

Latest updates to the Gantenerumab Long-term Safety in AD Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous Revision: v3.6.0. This is a platform/software update and does not modify the study data or how the page presents trial information.SummaryDifference0.0%

- Check31 days agoChange DetectedAdded recruitment status note 'No longer looking for participants' and new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment header formatting was updated, and the revision tag was updated to v3.6.0 (replacing v3.5.5).SummaryDifference0.4%

- Check38 days agoChange DetectedRevision: v3.5.5 was applied to the page, signaling a minor maintenance update. This change does not modify any study details, eligibility criteria, or results.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page revision was updated to v3.5.4 from v3.5.3, indicating a minor technical update to the page. This change does not modify the study details or substantive content.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page’s footer revision/version has been updated from **Revision: v3.5.2** to **Revision: v3.5.3**, reflecting a site release rather than a change to the clinical study details.SummaryDifference0.0%

- Check88 days agoChange DetectedAdded revision: v3.5.2; removed revision: v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Gantenerumab Long-term Safety in AD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gantenerumab Long-term Safety in AD Clinical Trial page.